Wednesdays, 1:30-2:30pm
Location: CGRI 133
Email Dr. Maria Zajac-Kaye if you have any questions
| DATE | PRESENTER | PRESENTATION TITLE |
|---|---|---|
| January 7, 2026 | Julian Tobon (Opavsky Lab) | Identifying C17orf58 as A Critical Vulnerability in Peripheral T-cell Lymphoma |
| January 14, 2026 | Temitope Ogunmola (Zhang Lab) | Immune Senescence in Renal Cell Cancer |
| January 21, 2026 | Yoda Campaneria (Sayour Lab) | Harnessing driver mutations for personalized mRNA cancer vaccines |
| January 28, 2026 | Huijia Liu (Jobin Lab) | Overcoming lung cancer immunotherapy resistance via gut metabolites driven T cell activation |
| February 4, 2026 | Loa Bakhsh (Huang Lab) | Novel Therapeutic Strategies for Ovarian Cancer |
| February 11, 2026 | Jesus Mendoza (Sayour Lab) | RNA-LPAs Enhance CAR T-cell-mediated Anti-tumor Efficacy in Solid Tumors |
| February 18, 2026 | No class | |
| February 25, 2026 | 1:30pm – Arantxa Lazarte (mentor Dr. Jason Butler) 1:45pm – Archyshmaan Pattanaik (mentor Dr. Lizi Wu) 2:00pm – Jaclyn Shaw (mentor Dr. Jatinder Lamba) |
Rotation 3 Presentations for Cancer Biology concentration |
| March 4, 2026 | Gabriel Jobin (Roemeling Lab) | RNA nanoparticle immunotherapy targets lung megakaryocytes that activate anti-tumor T cells |
| March 11, 2026 | Bristy Potter (Zhang Lab) | Targeting the Nuclear Receptor NR4A1 in Cancer |
| March 18, 2026 | No class | Spring break |
| March 25, 2026 | Pedro Ramos (Kolb Lab) | The role of ANGPTL4 in Clear Cell Renal Cell Carcinoma and its therapeutic potential |
| April 1, 2026 | Eri Shi (Zhang Lab) | Immune reprogramming by AB-free kava suppresses lung tumorigenesis and progression 2. Targeting ER stress via IRE1α inhibition in TNBC under obese conditions |
| April 8, 2026 | Louis Cafaro (Mitchell Lab) | RNA Editing T Cells for Improved Tumor Homing in Adoptive Cellular Therapy |
| April 15, 2026 | Daniel Rincon Diaz (Zhang Lab) | Elucidating the Therapeutic Role and Efficacy of Dendrimer-STAT3 Inhibitor in Glioblastoma |
| April 29, 2026 | Ibtida Ishmam (Butler Lab) | Endothelial Fgl2/Fcgr2b Signaling Drives Aging-Associated Bone Marrow Niche Dysfunction and Hematopoietic Decline |